Close menu



Ipilimumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Ipilimumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Ipilimumab-like is a recombinant, stable isotope labelled monoclonal IgG1-Kappa antibody containing proteotypic peptides derived from Ipilimumab’s originator sequence. Labelled Ipilimumab-like is designed for use as an internal standard for quantitative analysis of Ipilimumab in plasma samples. Ipilimumab targets the CTLA-4 protein and is used to treat Melanoma and Renal Cell Carcinoma.

This product is for research use only and is not intended for diagnostic or therapeutic use.